Integra LifeSciences Holdings Corporation Profile Avatar - Palmy Investing

Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tis…
Medical - Devices
US, Princeton [HQ]
Financials

Analysts

Earnings
Reported
Past Estimate Consensus
Future Estimate Consensus
EPS Revenue EBITDA EBIT SGA
FY EPS Revenue [mil.] Profit [mil.] EBITDA [mil.] EBIT [mil.] Expenses · SGA [mil.]
E E E E E E
All monetary values are presented in USD ($). E stands for Estimate.
2014 -0.3000 1.750 836 780 -16 32 88 122 43 63 394 434
2015 0.5200 1.544 928 882 34 -5 77 116 65 59 445 422
2016 -0.0476 1.756 882 994 -3 70 94 183 79 112 415 441
2017 1.0000 1.858 992 1,174 74 58 130 130 115 43 455 599
2018 0.8300 2.390 1,188 1,470 64 57 66 219 44 104 624 652
2019 0.7300 2.738 1,472 1,519 60 45 143 209 110 87 690 648
2020 0.5900 2.354 1,517 1,372 50 108 206 256 158 129 687 579
2021 1.5800 3.177 1,371 1,540 133 144 192 300 151 169 594 543
2022 2.0000 3.313 1,542 1,558 169 161 240 322 197 214 637 619
2023 2.1800 3.107 1,557 1,544 180 67 276 354 238 235 616 680
2024 - 2.449 - 1,613 - 196 - 258 - 129 - 674
2025 - 2.505 - 1,697 - 200 - 272 - 136 - 710
2026 - 2.743 - 1,791 - 1.F12X/td> - 1.F121/td> - 1.F121 - 1.F121
2027 - 3.410 - 1,965 - 0.F13X/td> - 0.F131/td> - 0.F131 - 0.F131
Institutional Sentiment
Morgan Stanley
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
JP Morgan Chase
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
Citigroup
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
Overall Consensus
Grading Consensus
Click to each, to see the grade
Price Target Consensus

-24.478% $5.63 · MISS

Nov. 6, 2024
Price Then
$24.91
Price Target
$28.63
Price Now
$23.00
End of IART's Analysis
CIK: 917520 CUSIP: 457985208 ISIN: US4579852082 LEI: - UEI: -
Secondary Listings
IART has no secondary listings inside our databases.